e-Article
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial
Document Type
Article
Author
Moodie, Z.; Andersen-Nissen, E.; Grunenberg, N.; Dintwe, O.B.; Kee, J.J.; Miner, M.D.; Ramirez, S.; Nebergall, M.; Takuva, S.; De Rosa, S.; Kublin, J.G.; McElrath, M.J.; Corey, L.; Omar, F.L.; Bekker, L.-G.; Laher, F.; Naicker, N.; Jani, I.; Mgodi, N.M.; Hunidzarira, P.; Sebe, M.; Mngadi, K.; Polakowski, L.; Sikhosana, L.; Heptinstall, J.; Seaton, K.E.; Tomaras, G.D.; Diazgranados, C.A.; Koutsoukos, M.; Meeren, O.V.D.; Barnett, S.W.; Kanesa-Thasan, N.; Goepfert, P.
Source
In: PLoS Medicine . (PLoS Medicine, March 2024, 21(3))
Subject
Language
English
ISSN
15491676
15491277
15491277